Shearman And Sterling

Gene is Special Counsel in the Derivatives & Structured Products practice.

Gene’s practice focuses on funds, investment banks, corporations and other financial market participants on a full range of legal and documentation matters related to the structuring and documentation of various derivative, prime brokerage and other structured product transactions across all major asset classes.

Gene has notable expertise in negotiating trading and clearing documentation, including those in respect of prime brokerage arrangements and related products and issues (margin lockups, fixed income clearing, arranged financing, cross-margining, custody and rehypothecation), OTC derivatives, exchange-traded derivatives, securities lending, agency lending and digital assets.  Gene also advises market participants with respect to regulatory developments and implementation in respect of derivatives and other financial products.

Gene has extensive experience over his 20+ years as an attorney.  He provides a unique perspective to clients, having spent significant time both in private practice and as in-house counsel with several investment banks.  Prior to joining Shearman & Sterling in early 2022, Gene spent five years as an associate at Cravath, Swaine & Moore and then served in various roles as internal counsel to investment banks such as Bear Stearns, JPMorgan, Societe Generale and Credit Suisse.